Kangmei Pharma | 600518 - Operating Profit


Kangmei Pharma reported CNY-10.94M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Genomma Lab Internacional MXN 874.42M 73.81M Mar/2026
Hypermarcas BRL 505.89M 141.31M Mar/2026
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 266M 49M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD -20.2M 137.3M Mar/2026
Wuxi Apptec CNY 5.11B 435.53M Mar/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026